BioSpace News Archive

Four leading pharmaceutical companies partnered with Amazon Web Services and Israel Biotech Fund to launch AION Labs, an innovation space that will allow drug developers to harness AI and computational science to solve therapeutic challenges.

On October 6, 2021, Bristol Myers Squib and Celgene terminated the original deal related to Abraxane and gave BeiGene 180 days of notice that it was withdrawing Abraxane from the deal.

Biopharma and life sciences companies strengthen their leadership teams and executive boards with these Movers & Shakers.

According to CNN, Califf is being vetted by the administration of Joe Biden, who served as vice president to Obama.

Genentech, a member of the Roche Group, announced new longer-term efficacy and safety data for Enspryng™.

Adocia announced that its partner Tonghua Dongbao Pharmaceutical Co. Ltd. received clearance from the Center for Drug Evaluation of the China National Medical Products Administration to conduct the Phase 3 clinical trial of BioChaperone® Lispro, an Ultra-Rapid Insulin for the treatment of Type 1 and Type 2 diabetes.

Temporomandibular joint (TMJ) implants are medical devices that are used to replace partial or the total jaw.

According to the report, the global sepsis treatment market was valued over US$ 600 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

Transparency Market Research has published a new report titled, ‘Global Rubber Gloves Market’.

Rehabilitation equipment plays a significant role in improving the quality of life of the sick, disabled, injured, and aged population.